These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19888878)

  • 1. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
    Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ
    J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and characterization of catalase in albumin microspheres.
    Siwale RC; Oettinger CW; Pai SB; Addo R; Uddin N; Siddig A; D'Souza MJ
    J Microencapsul; 2009 Aug; 26(5):411-9. PubMed ID: 18821261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats.
    Patel N; Addo RT; Ubale R; Uddin MN; D'Souza M; Jobe L
    J Drug Target; 2014 Nov; 22(9):796-804. PubMed ID: 24892743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A methodology for quantitation and characterization of oligonucleotides in albumin microspheres.
    Uddin MN; Do DP; Pai SB; Gayakwad S; Oettinger CW; D'Souza MJ
    Analyst; 2009 Jul; 134(7):1483-9. PubMed ID: 19562219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides.
    Akhavein N; Oettinger CW; Gayakwad SG; Addo RT; Bejugam NK; Bauer JD; Do D; Pollock SH; D'souza MJ
    J Microencapsul; 2009 May; 26(3):223-34. PubMed ID: 18666015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST; Devi SG; KV S
    AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
    De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
    J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone.
    Pavanetto F; Genta I; Giunchedi P; Conti B; Conte U
    J Microencapsul; 1994; 11(4):445-54. PubMed ID: 7931944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro characterization of spray dried microspheres of amoxicillin.
    Raval JA; Patel JK; Patel MM
    Acta Pharm; 2010 Dec; 60(4):455-65. PubMed ID: 21169137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, characterization and in vitro evaluation of stavudine-loaded microspheres.
    Vaghani SS; Sureja S; Singh S; Gurjar M; Jivani NP; Patel MM
    Pharm Dev Technol; 2011 Apr; 16(2):146-51. PubMed ID: 20100058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release characteristics of polymethacrylate nanospheres containing coumarin-6.
    Eley JG; Tirumalasetty PP
    J Microencapsul; 2003; 20(5):653-9. PubMed ID: 12909548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.
    Srivastava AK; Ridhurkar DN; Wadhwa S
    Acta Pharm; 2005 Sep; 55(3):277-85. PubMed ID: 16375838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.
    Sultana S; Bhavna ; Iqbal Z; Panda BP; Talegaonkar S; Bhatnagar A; Ahmad FJ
    J Microencapsul; 2009 Aug; 26(5):385-93. PubMed ID: 18720200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2003; 20(1):57-65. PubMed ID: 12519702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.
    Sezer AD; Akbuğa J
    Pharm Dev Technol; 2012; 17(1):118-24. PubMed ID: 20977313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.